Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001678744-16-000001
Filing Date
2016-07-06
Accepted
2016-07-06 16:48:30
Documents
1
Effectiveness Date
2016-07-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6505
  Complete submission text file 0001678744-16-000001.txt   7558
Mailing Address 1140 BROADWAY SUITE 1100 NEW YORK NY 10001
Business Address 1140 BROADWAY SUITE 1100 NEW YORK NY 10001 (855)687-4363
Recombine Genomics, Inc. (Filer) CIK: 0001678744 (see all company filings)

EIN.: 811621764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-266453 | Film No.: 161754320